Items Tagged ‘genomic testing’

October 29th, 2015

Gene-Targeted Drug Can Treat Prostate Cancer

By

According to an international consortium of researchers led by experts at The Institute of Cancer Research, London, and The Royal Marsden, a pioneering drug developed to treat women with inherited cancers can also benefit men with advanced prostate cancer. Olaparib, the world’s first drug to reach the market targeted against inherited cancer mutations, was found […]

View full entry

Tags: advanced, DNA repair mutations, genomic testing, Locally Advanced Stage III (C) Prostate Cancer, Metastatic Stage IV (D) Prostate Cancer, News, olaparib, Prostate Cancer, treatment-resistant


August 6th, 2015

Protein Circulating in Blood Could Be Key to Early Diagnosis of Pancreatic Cancer

By

Research suggests a promising new way to screen for and detect early pancreatic cancer. Certain proteins that circulate in the blood may help identify patients with this disease, for which there’s currently no reliable screening. These findings were published in the journal Nature. Pancreatic cancer is one of the deadliest forms of cancer. Each year, […]

View full entry

Tags: cancer screening, genomic testing, News, Pancreatic Cancer, pancreatic screening, Screening/Prevention Pancreatic Cancer


June 9th, 2014

Data Demonstrates Benefit of Utilizing Multiple Biological Pathways to Predict Tumor Behavior in Prostate and Renal Cancers

By

REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ – Genomic Health, Inc. (Nasdaq: GHDX) today announced results of two studies demonstrating the ability of its Oncotype DX® test and a new 16-gene panel to predict disease aggressiveness and clinical outcomes in prostate and renal cancers, respectively. These results, presented at the American Society of Clinical Oncology® (ASCO®) Annual […]

View full entry

Tags: Early Stage I-II (A-B) Prostate Cancer, General Renal Cancer, genomic testing, kidney cancer, News, oncotype, Prostate Cancer, Renal Cancer